Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation
Status:
Completed
Trial end date:
2018-10-09
Target enrollment:
Participant gender:
Summary
The goal of the present study is to evaluate if addition of methotrexate can restore
remission after loss of response to infliximab after dose escalation.
another goal is to evaluate if low dose methotrexate can maintain remission achieved by
regular dose methotrexate by 6 months.